Casma Therapeutics

Casma Therapeutics is a privately held clinical-stage biotechnology company founded in 2018 and headquartered at 201 Brookline Ave, Suite 1401, Boston, MA. Casma develops novel cellular degradation medicines built on the autophagy pathway — the conserved process cells use to clear damaged components. Its PHLYT (Phagosome-Lysosome Targeting) platform initiates target-specific autophagic degradation of disease targets independent of size or complexity, reaching beyond single proteins to organelles, protein aggregates and large signaling complexes, with programs spanning oncology, inflammation, neurodegeneration and metabolic disease. Casma was named to the Fierce 15 list in 2019. The company publishes no public developer API, developer portal, SDKs or machine-readable API contract; it is catalogued here as a company profile only.

Casma Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Drug Discovery.

Casma Therapeutics’ developer surface includes engineering blog and 14 more developer resources.

🌐 Visit website 📡 Source on GitHub

9.5/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-25 · rubric v0.14.0

0 APIs

Company Biotechnology Pharmaceuticals Life Sciences Drug Discovery TherapeuticsAutophagyHealth

Kin Score

Kin Score How this is scored →
scored 2026-08-25 · rubric v0.14.0

Composite quality — 9.5/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Surface 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/casma-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 6

The organization behind the API

Website

About

Blog

Careers

Investors

LinkedIn

Other 4

Properties that don't map to a standard resource type

Team

Science

Pipeline

SecondaryMarket

Source (apis.yml)

aid: casma-therapeutics
name: Casma Therapeutics
description: Casma Therapeutics is a privately held clinical-stage biotechnology company founded in 2018 and headquartered
  at 201 Brookline Ave, Suite 1401, Boston, MA. Casma develops novel cellular degradation medicines built on the autophagy
  pathway — the conserved process cells use to clear damaged components. Its PHLYT (Phagosome-Lysosome Targeting) platform
  initiates target-specific autophagic degradation of disease targets independent of size or complexity, reaching beyond single
  proteins to organelles, protein aggregates and large signaling complexes, with programs spanning oncology, inflammation,
  neurodegeneration and metabolic disease. Casma was named to the Fierce 15 list in 2019. The company publishes no public
  developer API, developer portal, SDKs or machine-readable API contract; it is catalogued here as a company profile only.
image: https://www.casmatx.com/wp-content/themes/casma/images/brand-logo.svg
url: https://raw.githubusercontent.com/api-evangelist/casma-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-02'
modified: '2026-08-02'
x-enrichment:
  date: '2026-08-02'
  status: minimal
  artifacts_added: 3
  pass: local-v1
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Drug Discovery
- Therapeutics
- Autophagy
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/casma-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/casma-therapeutics-llms.txt
- type: Website
  url: https://www.casmatx.com/
- type: About
  url: https://www.casmatx.com/about/
- type: Contact
  url: https://www.casmatx.com/contact-us/
- type: Blog
  url: https://www.casmatx.com/news-media/
- type: PrivacyPolicy
  url: https://www.casmatx.com/privacy-policy/
- type: TermsOfService
  url: https://www.casmatx.com/terms-of-use/
- type: Careers
  url: https://www.casmatx.com/careers-culture/
- type: Investors
  url: https://www.casmatx.com/investors/
- type: Team
  url: https://www.casmatx.com/our-team/
- type: Science
  url: https://www.casmatx.com/science/
- type: Pipeline
  url: https://www.casmatx.com/platform-pipeline/
- type: LinkedIn
  url: https://www.linkedin.com/company/casma-tx
- type: SecondaryMarket
  url: https://forgeglobal.com/casma-therapeutics_stock/

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/casma-therapeutics"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/casma-therapeutics/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/casma-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.